Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis

American Journal of Rhinology

Volumn 22, Issue 2, 2008, Pages 192-196

  Leung, Man Kit ^a   Rachakonda, Leelanand ^a   Weill, David ^a   Hwang, Peter H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cystic fibrosis; Heart lung transplant; Lung transplant; Outcomes; Pseudomonas; Rejection; Sinus surgery; Transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NOSE SURGERY; PREVALENCE; PSEUDOMONAS; SCHOOL CHILD; SURVIVAL;

ADOLESCENT; ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PARANASAL SINUSES; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; TRANSPLANTS; TREATMENT OUTCOME;

EID: 42449109129     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2008.22.3146     Document Type: Article

References (23)

1. Strausbaugh SD, and Davis PB. Cystic fibrosis: A review of epidemiology and pathobiology. Clin Chest Med 28:279-288, 2007.
2. Nishioka GJ, and Cook PR. Paranasal sinus disease in patients with cystic fibrosis. Otolaryngol Clin North Am 29:193-205, 1996.
3. Hadjiliadis D. Special considerations for patients with cystic fibrosis undergoing lung transplantation. Chest 131:1224-1231, 2007.
4. Nunley DR, Grgurich W, Iacono AT, et al. Allograft colonization and infections with Pseudomonas in cystic fibrosis lung transplant recipients. Chest 113:1321-1329, 1998.
5. Nunley D, Dauber J, Iacono A, et al. Unopposed neutrophil elastase in bronchoalveola lavage from transplant recipients with cystic fibrosis. Am J Respir Crit Care Med 159:258-261, 1999.
6. Lewiston N, King V, Umetsu D, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 23:1207-1208, 1991.
7. Walter S, Gudowius P, Bosshammer J, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 52:318-321, 1997.
8. Vricella LA, Karamichalis JM, Ahmad S, et al. Lung and heart-lung transplantation in patients with end-stage cystic fibrosis: The Stanford experience. Ann Thorac Surg 74:13-18, 2002.
9. Moffatt SD, Demers P, Robbins RC, et al. Lung transplantation: A decade of experience. J Heart Lung Transplant 24:145-151, 2005.
10. Moffatt SD, Karamichalis JM, Robbins RC, et al. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome? Ann Thorac Surg 81:286-291, 2006.
11. Yousem SA, Berry GJ, Philip CT, et al. Revision of the 1990 formulation for the classification of pulmonary allograft rejection: Lung rejection study group. J Heart Lung Transplant 15:1-15, 1996.
12. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation. J Heart Lung Transplant 12:713-716, 1993.
13. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 21:297-310, 2002.
14. The Organ Procurement and Transplantation Network (OPTN). Available online at www.OPTN.org; last accessed August 3, 2007.
15. Flume PA, Egan TM, Paradowski LJ, et al. Infectious complications of lung transplantation: Impact of cystic fibrosis. Am J Respir Crit Care Med 149:1601-1607, 1994.
16. Perloff JR, and Palmer JN. Evidence of bacterial biofilms in a rabbit model of sinusitis. Am J Rhinol 19:1-6, 2005.
17. Bendouah Z, Barbeau J, Hamad WA, et al. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991-996, 2006.
18. Chiu AG, Antunes MB, Palmer JN, et al. Evaluation of the in vivo efficacy of topical tobramycin against Pseudomonas sinonasal biofilms. J Antimicrob Chemother 59:1130-1134, 2007.
19. Spahr JE, Love, RB, Francois M, et al. Lung transplantation for cystic fibrosis: Current concepts and one center's experience. J Cyst Fibros 6:334-350, 2007.
20. Egan TM, Detterbeck FC, Mill MR, et al. Lung transplantation for cystic fibrosis: Effective and durable therapy in a high-risk group. Ann Thorac Surg 66:337-346, 1998.
21. Aurora P, Whitehead B, Wade A, et al. Lung transplantation and life extension in children with cystic fibrosis. Lancet 354:1591-1593, 1999.
22. Rosbe KW, Jones DT, Rahbar R, et al. Endoscopic sinus surgery in cystic fibrosis: Do patients benefit from surgery? Int J Pediatr Otorhinolaryngol 61:113-119, 2001.
23. Holzmann D, Speich R, Kaufmann T, et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: A 10-year experience. Transplantation 77:134-136, 2004.